< Back to previous page
Researcher
Karin Haustermans
- Disciplines:Radiation therapy, Cancer diagnosis, Cancer therapy, Cancer epidemiology
Affiliations
- Laboratory of Experimental Radiotherapy (Division)
Responsible
From1 Jan 2012 → Today - Laboratory of Experimental Radiotherapy (Division)
Member
From1 Oct 2005 → Today
Infrastructure
1 - 1 of 1
- The PaRtiCLE proton center. (Consortium coordinator)
Projects
1 - 10 of 40
- Outcome modeling in Proton TherapyFrom5 Apr 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Towards cost-effective patient selection for proton therapy in thoracic cancers: a framework for continuously updating prediction modelsFrom1 Oct 2023 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Real-time qPCR platform enhancing research activities within the Laboratory of Experimental Oncology and the Laboratory of Experimental RadiotherapyFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Implementation, optimisation and evaluation of proton therapy in esophageal cancerFrom1 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Proton versus Photon Therapy for Esophageal Cancer - a Trimodality StrategyFrom1 Jul 2021 → TodayFunding: H2020 - Health, demographic change and wellbeing
- The importance of the TNM Classification for Cancer Surveillance.From20 Oct 2020 → 30 Apr 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- Accurate patient-individual prediction of proton therapy benefit in thoracic cancers using 3D dose maps and radiomicsFrom1 Oct 2020 → 30 Sep 2023Funding: FWO junior postdoctoral fellowship
- Characterization of the biological benefits of ultra-high dose rate FLASH proton therapy.From31 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Organ preserving strategies in rectal cancerFrom10 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Optimization of overall treatment time for whole gland stereotactic body radiotherapy with integrated focal boosting in prostate cancerFrom6 Aug 2020 → 25 Apr 2024Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
291 - 300 of 365
- 5-Aminoimidazole-4-Carboxamide Riboside Enhances Effect of Ionizing Radiation in PC3 Prostate Cancer Cells(2011)
Authors: Johan Swinnen, Karin Haustermans
Pages: 1515 - 1523 - Single blind randomized Phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial(2011)
Authors: Karin Haustermans
- What is the role of IMRT and IGRT in rectal cancer?(2011)
Authors: Karin Haustermans
Pages: 129 - 148 - Quality of care indicators in rectal cancer(2011)
Authors: Karin Haustermans, Eric Van Cutsem, Freddy Penninckx
Pages: 445 - 450 - Insulin-Like Growth Factor–Type 1 Receptor Inhibitor NVP-AEW541 Enhances Radiosensitivity of PTEN Wild-Type but Not PTEN-Deficient Human Prostate Cancer Cells(2011)
Authors: Johan Swinnen, Karin Haustermans
Pages: 239 - 247 - EGF61 polymorphism predicts complete pathologic response to cetuximab-based chemoradiation independent of KRAS status in locally advanced rectal cancer patients(2011)
Authors: Annelies Debucquoy, Karin Haustermans
Pages: 5161 - 5169 - Diffusion-Weighted MRI for Selection of Complete Responders After Chemoradiation for Locally Advanced Rectal Cancer: A Multicenter Study(2011)
Authors: Vincent Vandecaveye, Maarten Lambrecht, Karin Haustermans
Pages: 2224 - 2231 - Altered Biodistribution of Somatostatin Analogues After First Cycle of Peptide Receptor Radionuclide Therapy(2011)
Authors: Sofie Van Binnebeek, Christophe Deroose, Kristof Baete, Michel Koole, Karin Haustermans, Luc Mortelmans, Chris Verslype, Eric Van Cutsem, Alfons Verbruggen, Felix Mottaghy
Pages: E579 - E581 - Prospective Evaluation of (11)C-Choline Positron Emission Tomography/Computed Tomography and Diffusion-Weighted Magnetic Resonance Imaging for the Nodal Staging of Prostate Cancer with a High Risk of Lymph Node Metastases(2011)
Authors: Steven Joniau, Evelyne Lerut, Felix Mottaghy, Christophe Deroose, Kris Bogaerts, Karin Haustermans, Hendrik Van Poppel
Pages: 125 - 130 - Strategies to improve radiocurability for prostate cancer: radiosensitizers and magnetic resonance imaging(2011)
Authors: Sofie Isebaert, Karin Haustermans, Johan Swinnen
Number of pages: 189